Tag: biomedical
-
Heart Research Built Into Personalized Activity Tracker
An activity tracking device introduced earlier this year uses data from a major population health study to write its algorithms measuring exercise achievement to prevent heart disease.
-
Spacecraft Returns with Space Station Research Samples
A SpaceX Dragon spacecraft returned today with samples from several biomedical research studies conducted by astronauts on the International Space Station.
-
Small Business Award Funding Epilepsy Drug Research
A federal grant is funding a project by Neuroene Therapeutics, a start-up enterprise in South Carolina to develop a new class of drugs to treat epilepsy.
-
Lower-Risk Blood Thinning Drugs Designed
Researchers from academic and industry labs designed anti-coagulation treatments for people in danger of blood clots, but less likely to cause excessive bleeding than current drugs.
-
Patent Set for Heart Tissue Regeneration Drug
A drug developed by MDI Biological Laboratory that stimulates growth of heart tissue to fix damage from heart attacks is scheduled to receive a U.S. patent.
-
University Spin-Off Developing Sepsis Drug
A spin-off enterprise from University of British Columbia is licensing a cholesterol-lowering drug from drug maker Novartis to develop a treatment for sepsis and other severe infections.
-
Stem Cells, Engineered Protein Reverse Stroke Damage
A combination of stem cells and synthetic human protein was shown in lab mice to repair damaged brain cells a week after an induced stroke.
-
FDA Giving Fast-Track Review to Alzheimer’s Candidate
U.S. Food and Drug Administration is giving an accelerated review to a candidate drug designed to treat Alzheimer’s disease by reducing the toxicity of amyloid beta proteins making up the plaque accumulating in the brain.
-
PhRMA: 258 Vaccines in Clinical Development
An industry group of American pharmaceutical makers says its companies have 258 vaccines, including immunotherapies, in clinical trials or awaiting FDA approval.
-
Genome Engineering Streamlines E. Coli DNA
A genetics engineering team developed a technique for modifying the genome of E. coli bacteria to remove redundant DNA components, a step toward designing new organisms.